No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2 | Adipocytokine signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
3 | African trypanosomiasis 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
4 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
5 | Allograft rejection 4 genes, 3 drugs (DrugBank), 27 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
6 | Alzheimer disease 6 genes, 2 drugs (DrugBank), 52 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
7 | Amoebiasis 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
8 | Amphetamine addiction 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
9 | AMPK signaling pathway 1 gene, 1 drug (DrugBank), 19 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
10 | Amyotrophic lateral sclerosis (ALS) 6 genes, 2 drugs (DrugBank), 52 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
11 | Antifolate resistance 3 genes, 2 drugs (DrugBank), 41 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
12 | Antigen processing and presentation 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
13 | Apoptosis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
14 | Asthma 3 genes, 3 drugs (DrugBank), 27 diseases shown |
[1] FCER1A |
D05251 |
Omalizumab |
[6] 53, 65, 98, 162, 226, 299 |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
15 | Autoimmune thyroid disease 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
16 | Axon guidance 6 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
17 | B cell receptor signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
18 | Bile secretion 1 gene, 1 drug (DrugBank), 19 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
19 | Breast cancer 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
20 | C-type lectin receptor signaling pathway 9 genes, 3 drugs (DrugBank), 54 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
21 | Calcium signaling pathway 6 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
22 | Cell cycle 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
23 | Cellular senescence 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
24 | Central carbon metabolism in cancer 2 genes, 1 drug (DrugBank), 11 diseases shown |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
25 | cGMP-PKG signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
26 | Chagas disease (American trypanosomiasis) 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
27 | Choline metabolism in cancer 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
28 | Chronic myeloid leukemia 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
29 | Cytokine-cytokine receptor interaction 6 genes, 4 drugs (DrugBank), 27 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
30 | Dilated cardiomyopathy (DCM) 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
31 | Dopaminergic synapse 3 genes, 1 drug (DrugBank), 44 diseases shown |
[3] PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
32 | Drug metabolism - other enzymes 2 genes, 2 drugs (DrugBank), 34 diseases shown |
[2] IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
[32] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
[34] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
33 | EGFR tyrosine kinase inhibitor resistance 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
34 | Endocytosis 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
35 | Epstein-Barr virus infection 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
36 | ErbB signaling pathway 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
37 | Fc epsilon RI signaling pathway 3 genes, 3 drugs (DrugBank), 27 diseases shown |
[1] FCER1A |
D05251 |
Omalizumab |
[6] 53, 65, 98, 162, 226, 299 |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
38 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
39 | Focal adhesion 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
40 | Folate biosynthesis 2 genes, 1 drug (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
41 | Gap junction 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
42 | Glioma 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
43 | Glucagon signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
44 | Glutamatergic synapse 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
45 | Graft-versus-host disease 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
46 | Hematopoietic cell lineage 4 genes, 4 drugs (DrugBank), 55 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[1] MS4A1 |
D02994 |
Rituximab |
[42] 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
47 | Hepatitis B 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
48 | Hepatitis C 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
49 | Herpes simplex virus 1 infection 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
50 | Human cytomegalovirus infection 7 genes, 3 drugs (DrugBank), 58 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
51 | Human immunodeficiency virus 1 infection 6 genes, 2 drugs (DrugBank), 52 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
52 | Human papillomavirus infection 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
53 | Human T-cell leukemia virus 1 infection 6 genes, 2 drugs (DrugBank), 52 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
54 | Hypertrophic cardiomyopathy (HCM) 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
55 | IL-17 signaling pathway 3 genes, 3 drugs (DrugBank), 24 diseases shown |
[1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
56 | Inflammatory bowel disease (IBD) 6 genes, 4 drugs (DrugBank), 27 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
57 | Influenza A 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
58 | Insulin resistance 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
59 | Intestinal immune network for IgA production 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
60 | JAK-STAT signaling pathway 5 genes, 3 drugs (DrugBank), 27 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
61 | Kaposi sarcoma-associated herpesvirus infection 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
62 | Legionellosis 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
63 | Leishmaniasis 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
64 | Long-term potentiation 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
65 | Malaria 2 genes, 2 drugs (DrugBank), 26 diseases shown |
[1] IL12A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
66 | MAPK signaling pathway 8 genes, 3 drugs (DrugBank), 58 diseases shown |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
67 | Measles 2 genes, 1 drug (DrugBank), 16 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
68 | Melanogenesis 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
69 | Melanoma 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
70 | Metabolic pathways 6 genes, 5 drugs (DrugBank), 61 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
[1] DHODH |
D00749 |
Leflunomide |
[10] 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
[2] IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
[32] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
[34] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
71 | MicroRNAs in cancer 2 genes, 1 drug (DrugBank), 11 diseases shown |
[2] ABL1, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
72 | mTOR signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
73 | Natural killer cell mediated cytotoxicity 6 genes, 2 drugs (DrugBank), 52 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
74 | Necroptosis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
75 | Neuroactive ligand-receptor interaction 1 gene, 6 drugs (DrugBank), 53 diseases shown |
[1] NR3C1 |
D07715 |
Clobetasol |
[2] 39, 162 |
D01272 |
Clobetasol propionate |
[1] 162 |
D07715 |
D07202 |
Halometasone |
[1] 162 |
D00472 |
Prednisolone |
[38] 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
D00980 |
D00981 |
D00982 |
D01239 |
D01998 |
D02156 |
D03301 |
D00473 |
Prednisone |
[44] 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
D08416 |
Prednisone acetate |
[6] 35, 40, 41, 49, 162, 224 |
76 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
77 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
78 | NOD-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
79 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
80 | One carbon pool by folate 2 genes, 1 drug (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
81 | Oocyte meiosis 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
82 | Osteoclast differentiation 6 genes, 2 drugs (DrugBank), 52 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
83 | Oxytocin signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
84 | Pathogenic Escherichia coli infection 2 genes, 2 drugs (DrugBank), 30 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
85 | Pathways in cancer 7 genes, 3 drugs (DrugBank), 27 diseases shown |
[3] ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
86 | PD-L1 expression and PD-1 checkpoint pathway in cancer 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
87 | Pertussis 4 genes, 2 drugs (DrugBank), 26 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
88 | Phospholipase D signaling pathway 3 genes, 2 drugs (DrugBank), 16 diseases shown |
[1] FCER1A |
D05251 |
Omalizumab |
[6] 53, 65, 98, 162, 226, 299 |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
89 | PI3K-Akt signaling pathway 2 genes, 1 drug (DrugBank), 11 diseases shown |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
90 | Prostate cancer 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
91 | Proteoglycans in cancer 2 genes, 2 drugs (DrugBank), 26 diseases shown |
[1] IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
92 | Purine metabolism 2 genes, 2 drugs (DrugBank), 34 diseases shown |
[2] IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
[32] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
[34] 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
93 | Pyrimidine metabolism 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] DHODH |
D00749 |
Leflunomide |
[10] 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
94 | Rap1 signaling pathway 2 genes, 1 drug (DrugBank), 11 diseases shown |
[2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
95 | Ras signaling pathway 3 genes, 1 drug (DrugBank), 11 diseases shown |
[3] ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
96 | Regulation of actin cytoskeleton 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
97 | Renin secretion 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
98 | Rheumatoid arthritis 3 genes, 3 drugs (DrugBank), 26 diseases shown |
[1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
[1] IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
99 | RIG-I-like receptor signaling pathway 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
100 | Shigellosis 2 genes, 2 drugs (DrugBank), 30 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
101 | Sphingolipid signaling pathway 2 genes, 2 drugs (DrugBank), 26 diseases shown |
[1] FCER1A |
D05251 |
Omalizumab |
[6] 53, 65, 98, 162, 226, 299 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
102 | Systemic lupus erythematosus 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
103 | T cell receptor signaling pathway 7 genes, 3 drugs (DrugBank), 53 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
104 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank), 19 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
105 | TGF-beta signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
106 | Th1 and Th2 cell differentiation 8 genes, 3 drugs (DrugBank), 52 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
107 | Th17 cell differentiation 7 genes, 3 drugs (DrugBank), 50 diseases shown |
[1] IL17A |
D10071 |
Ixekizumab |
[4] 37, 162, 269, 271 |
[1] IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
108 | TNF signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
109 | Toll-like receptor signaling pathway 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
110 | Toxoplasmosis 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
111 | Tuberculosis 9 genes, 3 drugs (DrugBank), 54 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
112 | Type I diabetes mellitus 3 genes, 2 drugs (DrugBank), 26 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
113 | Type II diabetes mellitus 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
114 | VEGF signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
115 | Viral myocarditis 1 gene, 1 drug (DrugBank), 11 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
116 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
117 | Wnt signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
118 | Yersinia infection 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |